Platform

Our platform enables real-world enterprise applications to be developed using blockchain technology. Enterprise adoption of blockchain technology remains extremely limited, primarily as, outside of innovation departments, nobody cares about technology, only the business problems that it can solve. Blockchain is a critical component in all our enterprise solutions but as the backend for creating tokens that enables our clients to solve business problems. 


Over the last 10 years we have successfully deployed enterprise blockchain solutions across a whole range of industries, some examples, and links we provide below. The crypto industry is crying out for real world use cases of blockchain technology. Our solutions have been battle-test in production by some of the most demanding clients on earth. 

Timestamping

KSI is an cryptographic timestamping service that was developed to address the challenge of data integrity within the Estonian Government and is used as an alternative to Public Key Infrastructure. The implication is that the verification of issued timestamps does not rely on the security of cryptographic keys. This service is used today in production by governments authorities around the world to guarantee the integrity of archived data.
For more information see here 

Pharma Physical Supply Chain

We have developed a last-mile supply chain solution for pharma manufacturers that enables real-time counterfeit and diversion detection, liability management against false claims and visibility into pharmacovigilance. Integration into the SAP Information Collaboration Hub enables a digital token to be created for each GS1 code helping front-line care workers verify the authenticity and provenance of pharma products and giving manufacturers real-time visibility into the last-mile.
For more information see here 

Health-Care Real World Data

Together with Roche and Astra Zeneca we have developed a real-world data engine that enables pharma market access to get aggregate results of medicine use across a population without revealing any personal information from the health and disease registries. Applications include indication and combination-based pricing, value-based pricing, clinical trial patient enrolment and differentiated rebates.
For more information see here